# Vimta Labs Ltd-$ (VIMTALABS)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹450.3
Day Change: +0.11%
52W High: ₹902.85
52W Low: ₹377.3
Market Cap: ₹2,011 Cr

## Valuation
P/E: 26.18
P/B: 4.83
EPS: ₹17.2
Book Value: ₹93.23
Dividend Yield: 0%

## Returns
1Y Return: -30.75%

## Profitability
ROE: 18.55%
ROCE: 32.67%
Debt/Equity: 0.01
Revenue Growth: 16.9%
Profit Growth: 18.2%
EBITDA Margin: 36.16%
Operating Margin: 26.22%

## About
Vimta Labs Ltd-$ is a Diagnostics & Research company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Vimta Labs Ltd-$ makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- GuruFocus.com: Vimta Labs Ltd (BOM:524394) Q4 2026 Earnings Call Highlights: Strong Financial Performance and ...

## Access
Current tier: anonymous
More history: Register free to see 6 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.656Z
Price History Updated: 2026-05-18T22:58:56.438Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:56.438Z
Quant Updated: 2026-05-18T22:58:56.438Z
Sentiment Updated: 2026-05-18T22:58:56.438Z
Financials Status: current
Financials Updated: 2026-05-19T01:31:07.742Z
Financials Last Attempt: 2026-05-19T01:31:07.742Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹343.98 Cr
Operating Profit: ₹90.6 Cr (OPM 26.34%)
Net Profit: ₹67.34 Cr
Tax: ₹22.25 Cr

## Annual P&L History
FY25: Rev ₹343.98Cr | PAT ₹67.34Cr | OPM 26.34%
FY24: Rev ₹288.6Cr | PAT ₹41.01Cr | OPM 22.34%
FY23: Rev ₹315.06Cr | PAT ₹48.17Cr | OPM 22.12%

## Balance Sheet (FY25)
Total Assets: ₹466.53 Cr
Total Liabilities: ₹87.68 Cr
Borrowings: ₹8.52 Cr
Cash: ₹15.84 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sivalinga Prasad Vasireddi, Executive Chairman
- Harita  Vasireddi, MD & Whole Time Director
- Siva Rama Krishna Kambhampati, Chief Financial Officer
- Harriman  Vungal D.Tech, Executive Director of Operations, Member of Scientific Advisory Board & Executive Director
- Sujani  Vasireddi, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/vimtalabs
Disclaimer: For research and education only. Not investment advice.